The phrase "a safety analysis of" is correct and usable in written English.
You can use it when discussing the examination or evaluation of safety measures or protocols related to a specific subject or situation.
Example: "The report includes a safety analysis of the new construction site to ensure compliance with regulations."
Alternatives: "an evaluation of safety" or "a review of safety measures".
This paper presents a safety analysis of one box-building that suffered collapse on December 2007.
As stated in the IAEA Safety Requirements for Design of NPPs "a safety analysis of the plant design shall be conducted in which methods of both deterministic and probabilistic analysis shall be applied".
A safety analysis of RA patients treated with rituximab in combination with MTX in clinical trials showed that 11% of patients developed a positive titer for HACA's at least once during treatment with rituximab [41].
But if we conduct a safety analysis of the workplace using the statisticians' trusty tool of the micromort, defined as a one-in-a-million chance of sudden death, we can begin to appreciate what various initiatives have actually achieved.
Berger et al. (2003) evaluated the long-term effects of omalizumab in children by performing a 24-week extension to the study by Milgrom et al. (2001), and completing a safety analysis of the core study.
However, a safety analysis of the ATAC trial [ 42] showed a surprisingly higher incidence of head and neck cancer with anastrozole compared with tamoxifen (10/3092 vs. 3/3094, respectively).
Ms. Galvin and police and fire officials in Milford said they would continue to "closely monitor" the club, hoping that it would carry out recommendations they made for improved adult supervision and track layout, as well as having the club obtain insurance and authorize a safety analysis study of the track.
However, for engineering purposes like a screening safety analysis of a defect-containing component it is usually preferable to use a deterministic lower bound.
The major side effects observed in this study were consistent with those reported in two previously conducted randomised controlled trials and a pooled safety analysis of a Sorafenib monotherapy trial for patients with advanced HCC [ 12, 34, 42].
Merck said data from a "preliminary safety analysis" of an additional year of patient follow-up, part of the study's original plan, did not show a statistically significant difference in the rate of heart attacks and strokes among patients who had been on Vioxx and those who had taken a placebo.
We previously reported the results of a comparative safety analysis of six FOLFOX4-regulatory studies with a total of 3359 colorectal cancer patients: 1515 from two Asian studies (J-PMS and MASCOT [ 11]) and 1844 from four Western studies (EFC2962 [ 1], N9741 [ 2], EFC4584 [ 3, 4], and MOSAIC [ 9, 10]) [ 29].
